Delivery Order SPE2DB22D2007-SPE2DB25FJ1TM

Award Date 5/22/25
Potential Completion Date 6/13/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $19,110.00 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a $7,242.15 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 120 capsules of the pharmaceutical product BRUKINSA 80 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment...
This is a $6,370.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a medication, with a performance period through June 25, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $14,484.30 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 120 capsules of the drug BRUKINSA 80 MG. The contract has an ultimate completion date of October 2, 2024. This award is part of a larger indefinite delivery contract with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which allows the agency to efficiently procure a range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,242.15 firm fixed price contract is for the supply of 4,565,585,855 units of the prescription drug BRUKINSA 80 MG CAPSULE 120S. The contract has an ultimate completion date of September 17, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4,568,105,568 units of the drug BRUKINSA 80 MG CAPSULE 120S, with a ceiling value of $6,370.00. The contract has an ultimate completion date of May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a $7,242.15 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of BRUKINSA 80 MG CAPSULE 120S, a prescription medication, to support federal healthcare programs. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 12, 2024. This contract is not set aside for any specific business type....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, a pharmaceutical product, at a firm fixed price of $6,370.00. The contract has an ultimate completion date of May 12, 2025 and was awarded on April 21, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.00 firm fixed price contract is for the delivery of BRUKINSA 80 MG CAPSULE 120S, with a completion date of June 3, 2025. This is a non-set-aside delivery order contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $14,484.30 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of the prescription medication BRUKINSA 80 MG CAPSULE 120S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1TM
    Delivery Order

This is a $6,370.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 120-count capsules of the drug BRUKINSA 80 MG. The contract has an ultimate completion date of June 13, 2025.

AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order contract is issued under that larger IDC, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

Generated 8/21/25, 9:46 AM